Tuesday, October 13, 2015

Mistakes Happen

Good morning folks, 
So yesterday the markets felt a bit tired as we came right up into resistance on several of the indexes. It was a fairly low volume, choppy market with very few stocks making big moves higher. Oil, materials and miners looked particularly weak after the run they had last week.
The IWM looks a bit extended and looks like it wants to take a pause while the IBB remains weak. 
The numbers out of China overnight were weak and it looks like that could set the tone for this mornings open. We also have the government shutdown babble heating up as we head into what really matters >>>Earnings season! From the little bit of earnings we have gotten so far it doesn't appear as though its going to be a strong quarter. The other concern I have is the amount of layoffs that continue to be announced. Earnings and employment are the two biggest indicators I pay attention too. If we have weak earnings and people losing jobs you have a recipe for a recession. 
No reason to panic lets see how the earnings season plays out at we get started with the financial institutions this week.

Stocks on my radar premarket


Bullish and may have a swing or lottos in play

Cautiously optimistic

Very Cautious may even present a short opportunity .
07:47:32am
10/13/15
Aoxing Pharma +19% Premarket Following Earnings Report
Already gapping a bit nice base on the daily looks like it wants to test the 2 roll small float  could set up for a day trade Can be a pop and flopper China name may need to raise cash soon
 am Intec Pharma announces results of the food effect study of the Phase 3 formulation of its leading product candidate, Accordion Pill Carbidopa/Levodopa; results demonstrated that plasma concentrations of carbidopa and levodopa were similar (NTEC) 
Super Tiny Float recent IPO looking at a 6 dolla holla  Negative cash flow could need to raise more capital  DO not Chase it look for some heavy volume and an intraday setup 
Silver Spring Networks (SSNI) announced it has been selected to deliver an intelligent LED street lights network in Halifax, Nova Scotia, Canada.
Full disclosure I own this for a long term hold/swing Like the daily and long term story solid balance sheet, good growth moving forward and great earnings last 2 quarters If it can get through 15.20 with conviction 16.50 would be my target but if this little flag fails needs to hold 12.50 
Yandex N.V. and Microsoft (MSFT) announce strategic cooperation agreement (YNDX) : Microsoft and Yandex have announced a strategic cooperation agreement, to make it easy for people in Russia, Belarus, Kazakhstan, Ukraine, Turkey, and several other countries in the region to upgrade to a custom experience with Windows 10, where Yandex will be offered as the default homepage and search for the Microsoft Edge browser as well as IE across Windows 10 devices.
Thinking this could be a value play potential double bottom could go test 14 but more of a swing type
Transgenomic (TBIO) announced that it presented a poster last week at CAP '15, the annual meeting of the College of American Pathologists. The poster, which was co-authored by researchers from Amgen (AMGN), reported on the results of analysis of tumor tissue from two randomized clinical trials using Sanger sequencing. The analysis concluded that the use of validated assays, relevant controls, and assay-specific tissue requirements resulted in highly reproducible Sanger sequencing data from the FFPE clinical specimens
SUPER small floater likely needs to raise cash soon but could get a nice  day trade pop from a dolla roll

Energous Corporation Receives First Utility and Design Patents for Its Over-the-Air Charging Solution
nice to get the patents but that needs to equate to sales tiny floater clear downtrend can be a pop and flopper don't chase it but could get fun on a 7 roll 

Zosano Pharma Announces Positive Phase 2 Results for Its ZP-Glucagon Patch Program for Treatment of Severe Hypoglycemia
another super tiny floater recent IPO >Phase 2 data long way to go before they have an approved drug but these thin floaters can run DO NOT CHASE watch the volume
 
08:33:52am
UPDATE: 8-K Twitter Sees Q3 Rev. At High End Of $545M-$560M, With Adj. EBITDA At High End Of Previously Announced $110M-$115M
Full disclosure still holding half my swing looking for it to try and tag 35 If it were to get back down to the 26 and change range I will be adding
08:49:40am
10/13/15
Leerink: Time To Buy Nabriva Therapeutics' 'Unique Differentiation'
08:44:16am
10/13/15
RBC Capital Initiates Coverage on Nabriva Therapeutics at Outperform, Announces $21.00 PT
2.45 million float look for volume recent IPO could be a runner but do not chase it 


No comments:

Post a Comment